ADC药物兴起：默克密理博与龙沙加大生产投资，BioNTech在FDA申报前增加CMO合作——医药技术动态
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
#Lonza invest#Pharmaceutical Technology#FDA filing#BioNTech adds#adds CMOs